Literature DB >> 10205633

Effect of the formulation on the in-vitro release of propranolol from gellan beads.

F Kedzierewicz1, C Lombry, R Rios, M Hoffman, P Maincent.   

Abstract

Gellan gum beads of propranolol hydrochloride, a hydrophilic model drug, were prepared by solubilising the drug in a dispersion of gellan gum and then dropping the dispersion into calcium chloride solution. The droplets formed gelled beads instantaneously by ionotropic gelation. Major formulation and process variables which might influence the preparation of the beads and the drug release from gellan gum beads were studied. Very high entrapment efficiencies were obtained (92%) after modifying the pH of both the gellan gum dispersion and the calcium chloride solution. The beads could be stored for 3 weeks in a wet or dried state without modification of the drug release. Oven-dried beads released the drug somewhat more slowly than the wet or freeze-dried beads. The drug release from oven-dried beads was slightly affected by the pH of the dissolution medium. Gellan gum could be a useful carrier for the encapsulation of fragile drugs and provides new opportunities in the field of bioencapsulation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10205633     DOI: 10.1016/s0378-5173(98)00351-2

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

1.  A pseudo-randomised clinical trial of in situ gels of fluconazole for the treatment of oropharngeal candidiasis.

Authors:  Harish M Nairy; Narayana R Charyulu; Veena A Shetty; Prabhu Prabhakara
Journal:  Trials       Date:  2011-04-19       Impact factor: 2.279

2.  An automated two-phase system for hydrogel microbead production.

Authors:  Daniela F Coutinho; Amir F Ahari; Nezamoddin N Kachouie; Manuela E Gomes; Nuno M Neves; Rui L Reis; Ali Khademhosseini
Journal:  Biofabrication       Date:  2012-08-23       Impact factor: 9.954

3.  Statistical optimization of floating pulsatile drug delivery system for chronotherapy of hypertension.

Authors:  Sanjay J Kshirsagar; Shrikant V Patil; Mangesh R Bhalekar
Journal:  Int J Pharm Investig       Date:  2011-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.